BREAKING: Oxford and AstraZeneca's COVD-19 vaccine trials put on a hold after a UK participant had a 'serious' suspected reaction to the leading shot candidate

Phase 3 trials for the coronavirus vaccine being developed by Oxford University and AstraZeneca have been placed on a hold after a 'serious adverse event' was reported in a participant in the UK, according to Stat News. 

Serious adverse events are suspected reactions to vaccines or drugs that require hospitalization, are life-threateningly or deadly. 

It's unclear what the exact nature of the reaction was, but a person familiar with the matter told Stat News that the person is expected to recover. 

Trial holds are not uncommon, but it is a blow to worldwide hopes for a shot to be ready in the coming months, as the AstraZeneca shot was considered by many - including the World Health Organization - to be the leading candidate worldwide. 

Phase 3 trials for the coronavirus vaccine being developed by Oxford University and AstraZeneca have been placed on a hold after a 'serious adverse event' was reported in a participant in the UK

Phase 3 trials for the coronavirus vaccine being developed by Oxford University and AstraZeneca have been placed on a hold after a 'serious adverse event' was reported in a participant in the UK

Popular posts from this blog

Study Abroad USA, College of Charleston, Popular Courses, Alumni

Edinburgh Napier University Admission Process

Interest rate cap on credit union is raised